Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.

About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/241703
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/241703
If you spot an error, please let us know at [email protected].

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

DAVID CAMIDGE

Listed Specialty: Medical Oncology
12605 E 16TH AVE, AURORA, CO, 80045-2545

2018 Payments: At a Glance

87

payments

$132,598

payment total

12

companies paid this doctor

Types of Payments

Category Payments Payment Value
Consulting
 30 $95,199
Promotional Speaking/Other
 17 $25,070
Travel and Lodging
 17 $10,486
Food and Beverage
 23 $1,843

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
Payments with no listed product

N/A

 $41,339
ALUNBRIG

drug

 $39,751
LORBRENA

drug

 $10,210
XALKORI

drug

 $9,560
ALECENSA

drug

 $8,045
LIBTAYO

drug

 $6,477
NON-COVERED PRODUCT

drug

 $5,292
AVASTIN

drug

 $5,280
HERCEPTIN

drug

 $5,280
LUCENTIS

drug

 $5,280
RITUXAN

drug

 $5,280
TAMIFLU

drug

 $5,280
IMFINZI

drug

 $4,876
GILOTRIF

drug

 $3,320
CYRAMZA

drug

 $700
EMD 1214063

drug

 $60
BAVENCIO

drug

 $53
TAGRISSO

drug

 $19
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

Payment Details

When How Much Related To What For From Third Party Payee
Nov 30, 2018 $11,700 ALUNBRIG Consulting TAKEDA PHARMACEUTICALS U.S.A., INC. UNIVERSITY OF COLORADO, SCHOOL OF MEDICINE
Feb 16, 2018 $9,000 ALUNBRIG Consulting TAKEDA PHARMACEUTICALS U.S.A., INC. UNIVERSITY OF COLORADO AT DENVER
Sep 22, 2018 $8,700 ALUNBRIG Consulting TAKEDA PHARMACEUTICALS U.S.A., INC.
Oct 20, 2018 $7,919 No Listed Product Travel and Lodging ABBVIE, INC.
May 3, 2018 $7,200 ALUNBRIG Consulting TAKEDA PHARMACEUTICALS U.S.A., INC. UNIVERSITY OF COLORADO, SCHOOL OF MEDICINE
Jun 21, 2018 $6,250 No Listed Product Consulting DAIICHI SANKYO INC.
Mar 28, 2018 $5,280 AVASTIN HERCEPTIN LUCENTIS RITUXAN TAMIFLU Consulting GENENTECH USA, INC.
Jun 21, 2018 $4,531 No Listed Product Consulting DAIICHI SANKYO INC.
Feb 1, 2018 $4,162 IMFINZI Consulting ASTRAZENECA PHARMACEUTICALS LP
Mar 22, 2018 $4,063 No Listed Product Consulting DAIICHI SANKYO INC.
Jan 3, 2018 $3,750 No Listed Product Consulting DAIICHI SANKYO INC.
Sep 20, 2018 $3,525 LIBTAYO Consulting REGENERON PHARMACEUTICALS, INC.
May 9, 2018 $3,320 GILOTRIF Promotional Speaking/Other BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Dec 13, 2018 $3,200 LORBRENA Promotional Speaking/Other PFIZER INC.
Jan 25, 2018 $3,200 XALKORI Promotional Speaking/Other PFIZER INC.
Aug 2, 2018 $3,200 LORBRENA Promotional Speaking/Other PFIZER INC.
Jun 22, 2018 $2,820 LIBTAYO Consulting REGENERON PHARMACEUTICALS, INC.
Nov 9, 2018 $2,500 NON-COVERED PRODUCT Consulting GENENTECH USA, INC.
Sep 22, 2018 $2,330 ALECENSA NON-COVERED PRODUCT Consulting GENENTECH USA, INC.
Apr 26, 2018 $2,188 No Listed Product Consulting DAIICHI SANKYO INC.

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/241703

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.